-
National Rise and All-Human BCMA-Targeted CAR-T Therapy Brings New Hope for Relapsed/Refractory Multiple Myeloma Treatment
The 29th Annual Meeting of the European Hematology Association (EHA) was held from June 13 to 16, 2024, in Madrid, Spain. This conference, the largest international event in the field of hematology in Europe, attracts numerous renowned experts and scholars each year to share and discuss innovative ideas, the latest scientific research, and clinical findings…
-
Construction for Prostate Cancer Patients with a History of Malignancy by Professor Kan Gong ‘s Team | AUA 2024
With advancements in cancer screening, diagnosis, and treatment, the survival period of cancer patients has significantly increased. Long-term management of cancer patients should not only focus on the primary tumor but also monitor for the occurrence of secondary primary tumors (SPTs) and multiple primary tumors through regular check-ups and screenings. Secondary primary tumors are defined…
-
EHA Roundtable | Professor Xiaohui Zhang’s Team Wins YoungEHA Best Abstract Award: Comprehensive Analysis of Outstanding Research Results
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held from June 13-16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world each year to share and discuss innovative concepts and the latest scientific and clinical…
-
EHA Expert Interview | Professor Jun Ma: China’s Innovative Contributions Draw Global Attention, Major Breakthroughs in AML
The 29th Annual Meeting of the European Hematology Association (EHA) was grandly held from June 13-16, 2024, in Madrid, Spain. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world each year to share and discuss innovative concepts and the latest scientific and clinical…
-
ASCO2024 Navigator Conversation
Live Streaming Time: June 5, 19:00 (UTC+8)
-
EASL Expert Interview | Overcoming Limitations in Liver Cancer Screening: Application and Prospects of “HelioLiver Dx” in Early Diagnosis of Liver Cancer
Traditional screening methods in the field of liver cancer prevention and treatment face numerous challenges. At the 2024 European Association for the Study of the Liver (EASL) Annual Meeting, the CLiMB trial, led by Professor Richard Van Etten, Director of the UCI Chao Family Comprehensive Cancer Center in the United States, achieved significant results in…
-
EASL Expert Interview with Professor Frank Tacke: Interpretation of the EASL-EASD-EASO Clinical Practice Guidelines on Metabolic Associated Fatty Liver Disease
At the recently concluded European Association for the Study of the Liver (EASL) annual meeting, Professor Frank Tacke from Charité—Universitätsmedizin Berlin presented a special report on the newly released “Clinical Practice Guidelines for the Management of Metabolic Associated Fatty Liver Disease” by EASL, the European Association for the Study of Diabetes (EASD), and the European…
-
Preview of APACC 2024丨Dr. Woo Yin Ling: ROSE Program for HPV Screening
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2024 will be held in Hong Kong as a hybrid conference on 27-29 June 2024. During Parallel Session 5: Women’s Health – HPV, Dr. Woo Yin Ling from University of Malaya / University Malaya Medical Centre will deliver a presentation titled “Screening HPV – Rose Project”.
Connecting Medical Expertise through Media